OCTAGON CAPITAL ADVISORS LP – 4D Molecular Therapeutics, Inc. Transaction History
OCTAGON CAPITAL ADVISORS LP portfolio value:
$4.02M
portfolio value
OCTAGON CAPITAL ADVISORS LP quarter portfolio value change:
+15.19%
quarter
4D Molecular Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -20.98% | -132.74K shares | -397K | $8.04 | 499.99K |
| Q2 2022 | share | Decrease | -59.62% | -934.15K shares | -19.27M | $6.98 | 632.74K |
| Q1 2022 | share | Increase | +1.02% | 15.82K shares | -10.33M | $15.12 | 1.56M |
| Q4 2021 | share | Increase | +86.59% | 719.80K shares | 11.61M | $21.87 | 1.55M |
| Q3 2021 | share | 0.00% | 0 shares | 2.40M | $26.97 | 831.26K | |
| Q2 2021 | share | Increase | +119.74% | 452.97K shares | 3.60M | $24.08 | 831.26K |
| Q1 2021 | share | Increase | +0.14% | 511 shares | 751K | $43.38 | 378.28K |
| Q4 2020 | share | Increase | 0.00% | 377.77K shares | 15.65M | $41.45 | 377.77K |